Fatal cases of farmer's lung (FL) are rare. We found, based on death certificates, 13 cases of FL with a fatal outcome in Finland between 1980 and 1990. Compared with incidence data from the years 1980 to 1982, the mortality was estimated as 0.7 percent. On average, death occurred 8 years after the diagnosis of FL. One patient died acutely after a heavy mold exposure. The other patients had chronic disease. Among them the immediate cause of death was pneumonia in seven patients, respiratory insufficiency in four, and pneumoAcute farmer's lung (FL) usually has a good prognosis. However, in some patients the disease leads to a chronic phase with pulmonary fibrosis that may lead to death.12 A fatal case of acute FL has also been reported.3 In long-term follow-up studies, the mortality associated with FL has ranged from 0 to 17 percent. 1, [4] [5] [6] [7] [8] [9] To assess the mortality of FL, we have reviewed death certificates and clinical data of patients who had hypersensitivity pneumonitis as the underlying cause of death in Finland between the years of 1980 and 1990.
MATERIALS AND METHODS
In Finland, the death certificates are sent from the doctor signing the document to local and provincial medico-legal officers. After 
RESULTS
The clinical data of the 13 patients with FL as the underlying cause of death are presented in Table 1 . All patients fulfilled the diagnostic criteria of FL presented by Terho12 and all had chest radiograph changes compatible with FL. The mean age of the patients was 52 years at the time of the diagnosis and 54 percent of them were women. Data of smoking habits were available for eight patients: all were nonsmokers. Before the diagnosis, 8 of 13 patients had suffered from symptoms of FL for more than 1 year. All the patients were full-time or part-time dairy farmers. Mold exposure in the cowhouse resulted usually from moldy hay or beddings.
Pulmonary function data were available only for some of the patients and were usually expressed as a percentage of the predicted values (Table 1) . Because the fatal cases were scattered throughout the country, different pulmonary function equipment and reference values were used, details of which were usually not available in the patient files. When measured, pulmonary diffusing capacity was impaired. Reduced forced vital capacity (FVC) (<80% of pred) was seen in six of ten patients.
At the time of the diagnosis of FL, 11 patients were treated with corticosteroids, usually with oral prednisolone. The patient with an acute fatal outcome of the disease had treatment with intravenous methylprednisolone. Data of the duration of corticosteroid treatment were available for eight patients: the duration varied from 6 weeks to 7 months.
Of 12 patients with follow-up data, 6 returned to work in the cowhouse after the diagnosis of FL. Chest radiograph normalized in one of these patients during the first 6 months after the diagnosis, and fibrotic changes remained in three patients. For two patients, data on radiographic recovery during the first year were not available. All these six patients later experienced recurrent attacks of the disease. The other six patients did not return to regular work in the cowhouse, although two of them still worked there occasionally. Radiographically, fibrotic changes persisted in five of these patients. For one patient, data concerning recovery of chest radiograph during the first year was unavailable.
At the time of the diagnosis of FL, four patients had arterial hypertension and one patient suffered from diabetes. Later diabetes was diagnosed in three, arterial hypertension in one, coronary artery disease in one, and asthma and pulmonary tuberculosis in one patient. Cor pulmonale was diagnosed in eight patients. Four patients were on supplemental oxygen during the terminal phase of the illness.
Death occurred more than 5 years after the diagnosis of FL in 10 of 13 patients (Table 1) . One patient died acutely after 1 day following a heavy mold exposure (sacking moldy grain). In the other 12 patients, the immediate cause of death was pneumonia in 7, respiratory insufficiency in 4, and pneumothorax in 1 patient.
Autopsy was made in six patients. The patient, who died acutely after a heavy mold exposure had mononuclear cell infiltration in the lung and also numerous granulomas with epithelioid cells and giant cells. Fibrosis indicative of a chronic disease was seen. There were also patchy areas with abundant granulocytes in the lung compatible with pneumonia. In the other five patients, autopsy showed advanced pulmonary fibrosis. In three patients, there were mononuclear cell infiltration or scanty giant cells but no clear granulomas were found. In two patients pneumonia was evident. One patient had pulmonary tuberculosis and pneumothorax. Compared with the incidence data of FL during the period of 1980 to 1982, the mortality was calculated to be 0.7 percent. DISCUSSION We calculated the mortality based on data about the incidence of FL in the entire country from the years 1980 to 1982.13 These incidence data are representative, for in that nationwide study the same diagnostic criteria were used as in our study. Furthermore, the time at the beginning of 80s was close to the period when the diagnoses of FL were made in our series. We included only cases in which FL for a certainty was considered as an underlying cause of death.
We found 13 fatal cases of FL between 1980 and 1990 in Finland that resulted in a mortality of about 1 percent. In two Finnish studies with a mean follow-up of 5 years8'9 and one Canadian follow-up study7 no fatal cases of FL were reported. Three long-term follow-up studies in the 1960s and 1970s1, 4, 5 reported mortality of 9 to 17 percent associated with FL.
Emanuel and coworkers4 reported four fatal cases in a series of 24 patients. All of them had developed progressive pulmonary fibrosis as a consequence of FL. Barbee and coworkers' reported five fatal cases in a series of 50 patients with a mean of 6 years of follow-up. All these patients had extensive lung disease. Braun All the other patients in our study had chronic FL. Death was attributed to respiratory insufficiency or pneumonia, and in one patient to pneumothorax. Two patients had pneumothoraces during the course of the illness. Emanuel and coworkers4 also reported recurrent pneumothoraces in an ultimately fatal case of FL.
Eight of our 13 fatal cases had suffered from symptoms of FL for more than 1 year before the diagnosis was made. This is considerably longer time than in our other series of 101 patients with FL, where 37 percent of patients had symptoms of FL more than 3 months before the diagnosis.9 Also in bird fancier's lung, a long symptomatic time before the diagnosis has been considered to be a major factor leading to the development of chronic disease. 14 The mainstay in the treatment of FL is the strict avoidance of the offending antigens. In conclusion, based on death certificates and incidence data of FL, we found about 1 percent mortality attributable to FL. Death occurred an average of 8 years after the diagnosis. Majority of the patients had a long symptomatic period before FL was diagnosed and had fibrotic changes in chest radiograph already at the time of the diagnosis of FL.
